CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services. Through a network of cGMP facilities across Europe and the US organized under five technology platforms – Peptides, Oligonucleotides, Lipids & Carbohydrates – Injectables - Highly Potent & Oncology - Small Molecules - Antibiotics - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.
- Peptide API Production - Solid-phase, Liquid-phase, Hybrid Synthesis - cGMP & non-cGMP - Oligonucleotides - Lipids - Carbohydrates
● Sterile Injectables
- New Development & Commercial Suites for Aseptic Filling with >60.000 units per day (Pre-filled Syringes, Liquid or Lyophilized Vials) - Packaging, Labeling & Logistics - Sterile Emulsion Technology - Large Pre-Filled Syringes - Clinical Trial Services
● Highly Potent & Oncology
- API Development & Commercial Manufacturing (SafeBridge Category 4, OEL ≤1 ng/m3) - New Development & Scale-up Capacity for Phase I/II Supply - Drug Product Development & Manufacturing - New Development Suite (CTD2) for Mid-scale (up to 20 kg) Oral Dosage Forms - Sterile Liquid & Lyophilisation - Primary & Secondary Packaging
● Small Molecules
- Development & Commercial Manufacturing - Intermediates - APIs & Excipients - Clinical Supply from Phase I – III - Proprietary & Generic Advanced Intermediates & APIs